Follow The Filings

INSP Inspire Medical Systems

Inspire Medical Systems earnings company data as of 8:01 PM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 2 Nov EPS 0.11 — —
Rev — — —

Insider trades

Open-market buys and sales by INSP's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INSP insider trades
  • None no insider bought on the open market
  • $202K sold by 2 insiders outside a trading plan
  • $464K sold by 2 insiders under 10b5-1 plans
  1. Jason P Kelly See Remarks
    Sale
    $57K 963 shares at $59.55 4.8% of stake
    Traded Aug 7 Filed Aug 11
  2. John Rondoni See Remarks
    Sale
    $114K 2,641 shares at $43.28 8.9% of stake
    Traded May 15 Filed May 19
  3. John Rondoni See Remarks
    Sale
    $30K 700 shares at $43.01 2.3% of stake
    Traded May 14 Filed May 15
  4. Shawn mcCormick Director
    Planned sale
    $32K 696 shares at $45.31 2.5% of stake
    Traded May 8 Filed May 11
  5. John Rondoni See Remarks
    Planned sale
    $11K 109 shares at $100.00 0.8% of stake
    Traded Jan 9 Filed Jan 12
  6. Shawn mcCormick Director
    Planned sale
    $167K 1,200 shares at $139.00 4.6% of stake
    Traded Dec 2, 2025 Filed Dec 4, 2025
  7. Shawn mcCormick Director
    Planned sale
    $255K 2,000 shares at $127.48 7.1% of stake
    Traded Nov 28, 2025 Filed Dec 1, 2025
  8. Myriam Curet Director
    Buy
    $804 5 shares at $160.72 +0.1% to stake
    Traded Mar 20, 2025–Apr 7, 2025 Filed Nov 24, 2025
  9. Myriam Curet Director
    Sale
    $616 6 shares at $102.59 0.2% of stake
    Traded May 8, 2025–Aug 8, 2025 Filed Nov 24, 2025

Also filed in the last 12 months, not counted as buying or selling: 38 stock grants and 18 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02
8-K 5.02,9.01
SCHEDULE 13G —
8-K 7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02,5.03,5.07,9.01
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.